325 related articles for article (PubMed ID: 26650101)
1. Combined Atomistic Molecular Calculations and Experimental Investigations for the Architecture, Screening, Optimization, and Characterization of Pyrazinamide Containing Oral Film Formulations for Tuberculosis Management.
Adeleke OA; Monama NO; Tsai PC; Sithole HM; Michniak-Kohn BB
Mol Pharm; 2016 Feb; 13(2):456-71. PubMed ID: 26650101
[TBL] [Abstract][Full Text] [Related]
2. Optimal Design, Characterization and Preliminary Safety Evaluation of an Edible Orodispersible Formulation for Pediatric Tuberculosis Pharmacotherapy.
Matawo N; Adeleke OA; Wesley-Smith J
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784947
[TBL] [Abstract][Full Text] [Related]
3. Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization.
Palem CR; Gannu R; Doodipala N; Yamsani VV; Yamsani MR
Arch Pharm Res; 2011 Oct; 34(10):1701-10. PubMed ID: 22076770
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro characterization of novel sildenafil citrate-loaded polyvinyl alcohol-polyethylene glycol graft copolymer-based orally dissolving films.
Xu LL; Shi LL; Cao QR; Xu WJ; Cao Y; Zhu XY; Cui JH
Int J Pharm; 2014 Oct; 473(1-2):398-406. PubMed ID: 25079431
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate.
Shi LL; Xu WJ; Cao QR; Yang M; Cui JH
Pharmazie; 2014 May; 69(5):327-34. PubMed ID: 24855822
[TBL] [Abstract][Full Text] [Related]
6. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids.
Maher EM; Ali AM; Salem HF; Abdelrahman AA
Drug Deliv; 2016 Oct; 23(8):3088-3100. PubMed ID: 26960680
[TBL] [Abstract][Full Text] [Related]
7. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.
Mehta SK; Jindal N
Colloids Surf B Biointerfaces; 2013 Jan; 101():434-41. PubMed ID: 23010052
[TBL] [Abstract][Full Text] [Related]
8. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
9. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid-loaded orodispersible strips: Methodical design, optimization and in vitro-in silico characterization.
Adeleke OA; Tsai PC; Karry KM; Monama NO; Michniak-Kohn BB
Int J Pharm; 2018 Aug; 547(1-2):347-359. PubMed ID: 29879506
[TBL] [Abstract][Full Text] [Related]
11. Design and optimization of kollicoat ® IR based mucoadhesive buccal film for co-delivery of rizatriptan benzoate and propranolol hydrochloride.
Salehi S; Boddohi S
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():230-244. PubMed ID: 30678908
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
13. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
[TBL] [Abstract][Full Text] [Related]
14. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation.
Rahman Z; Zidan AS; Khan MA
Int J Pharm; 2010 Nov; 400(1-2):49-58. PubMed ID: 20801200
[TBL] [Abstract][Full Text] [Related]
15. Formulation, characterization, and in vitro evaluation of bioadhesive gels containing 5-Fluorouracil.
Dhiman M; Yedurkar P; Sawant KK
Pharm Dev Technol; 2008; 13(1):15-25. PubMed ID: 18300096
[TBL] [Abstract][Full Text] [Related]
16. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
17. EFFECT OF POLYMER AND PLASTICIZER ON THIN POLYMERIC BUCCAL FILMS OF MELOXICAM DESIGNED BY USING CENTRAL COMPOSITE ROTATABLE DESIGN.
Zaman M; Hanif M; Qaiser AA
Acta Pol Pharm; 2016 Sep; 73(5):1351-1360. PubMed ID: 29638075
[TBL] [Abstract][Full Text] [Related]
18. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
El-Bary AA; Al Sharabi I; Haza'a BS
Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
[TBL] [Abstract][Full Text] [Related]
19. Formulation and characterization of taste masked ondansetron-magnesium aluminum silicate adsorption systems.
Kharb V; Saharan VA; Kharb V; Jadhav H; Purohit S
Drug Dev Ind Pharm; 2016 Aug; 42(8):1291-9. PubMed ID: 26641930
[TBL] [Abstract][Full Text] [Related]
20. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
